These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1180 related items for PubMed ID: 34999159

  • 1. Nonalbuminuric Diabetic Kidney Disease and Risk of All-Cause Mortality and Cardiovascular and Kidney Outcomes in Type 2 Diabetes: Findings From the Hong Kong Diabetes Biobank.
    Jin Q, Luk AO, Lau ESH, Tam CHT, Ozaki R, Lim CKP, Wu H, Jiang G, Chow EYK, Ng JK, Kong APS, Fan B, Lee KF, Siu SC, Hui G, Tsang CC, Lau KP, Leung JY, Tsang MW, Kam G, Lau IT, Li JK, Yeung VT, Lau E, Lo S, Fung S, Cheng YL, Chow CC, Huang Y, Lan HY, Szeto CC, So WY, Chan JCN, Ma RCW, Hong Kong Diabetes Biobank Study Group.
    Am J Kidney Dis; 2022 Aug; 80(2):196-206.e1. PubMed ID: 34999159
    [Abstract] [Full Text] [Related]

  • 2. Finerenone and Heart Failure Outcomes by Kidney Function/Albuminuria in Chronic Kidney Disease and Diabetes.
    Filippatos G, Anker SD, Pitt B, Rossing P, Joseph A, Kolkhof P, Lambelet M, Lawatscheck R, Bakris GL, Ruilope LM, Agarwal R.
    JACC Heart Fail; 2022 Nov; 10(11):860-870. PubMed ID: 36328655
    [Abstract] [Full Text] [Related]

  • 3. The Prognosis of Patients With Type 2 Diabetes and Nonalbuminuric Diabetic Kidney Disease Is Not Always Poor: Implication of the Effects of Coexisting Macrovascular Complications (JDDM 54).
    Yokoyama H, Araki SI, Kawai K, Yamazaki K, Shirabe SI, Sugimoto H, Minami M, Miyazawa I, Maegawa H, JDDM Study Group.
    Diabetes Care; 2020 May; 43(5):1102-1110. PubMed ID: 32144168
    [Abstract] [Full Text] [Related]

  • 4. Risk of cardiovascular disease, death, and renal progression in diabetes according to albuminuria and estimated glomerular filtration rate.
    Niu J, Zhang X, Li M, Wu S, Zheng R, Chen L, Huo Y, Xu M, Wang T, Zhao Z, Wang S, Lin H, Qin G, Yan L, Wan Q, Chen L, Shi L, Hu R, Tang X, Su Q, Yu X, Qin Y, Chen G, Gao Z, Wang G, Shen F, Luo Z, Chen Y, Zhang Y, Liu C, Wang Y, Wu S, Yang T, Li Q, Mu Y, Zhao J, Bi Y, Ning G, Wang W, Lu J, Xu Y, China Cardiometabolic Disease and Cancer Cohort (4C) Study Group.
    Diabetes Metab; 2023 Mar; 49(2):101420. PubMed ID: 36640827
    [Abstract] [Full Text] [Related]

  • 5. Circulating metabolomic markers linking diabetic kidney disease and incident cardiovascular disease in type 2 diabetes: analyses from the Hong Kong Diabetes Biobank.
    Jin Q, Lau ESH, Luk AO, Tam CHT, Ozaki R, Lim CKP, Wu H, Chow EYK, Kong APS, Lee HM, Fan B, Ng ACW, Jiang G, Lee KF, Siu SC, Hui G, Tsang CC, Lau KP, Leung JY, Tsang MW, Cheung EYN, Kam G, Lau IT, Li JK, Yeung VTF, Lau E, Lo S, Fung S, Cheng YL, Chow CC, Yu W, Tsui SKW, Tomlinson B, Huang Y, Lan HY, Szeto CC, So WY, Jenkins AJ, Fung E, Muilwijk M, Blom MT, 't Hart LM, Chan JCN, Ma RCW, Hong Kong Diabetes Biobank Study Group.
    Diabetologia; 2024 May; 67(5):837-849. PubMed ID: 38413437
    [Abstract] [Full Text] [Related]

  • 6. Risk of Rapid Kidney Function Decline, All-Cause Mortality, and Major Cardiovascular Events in Nonalbuminuric Chronic Kidney Disease in Type 2 Diabetes.
    Buyadaa O, Magliano DJ, Salim A, Koye DN, Shaw JE.
    Diabetes Care; 2020 Jan; 43(1):122-129. PubMed ID: 31796570
    [Abstract] [Full Text] [Related]

  • 7. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Koye DN, Magliano DJ, Reid CM, Jepson C, Feldman HI, Herman WH, Shaw JE.
    Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
    [Abstract] [Full Text] [Related]

  • 8. Association of estimated glomerular filtration rate and urine albumin-to-creatinine ratio with incidence of cardiovascular diseases and mortality in chinese patients with type 2 diabetes mellitus - a population-based retrospective cohort study.
    Fung CS, Wan EY, Chan AK, Lam CL.
    BMC Nephrol; 2017 Feb 02; 18(1):47. PubMed ID: 28152985
    [Abstract] [Full Text] [Related]

  • 9. Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With Finerenone.
    Agarwal R, Pitt B, Rossing P, Anker SD, Filippatos G, Ruilope LM, Kovesdy CP, Tuttle K, Vaduganathan M, Wanner C, Bansilal S, Gebel M, Joseph A, Lawatscheck R, Bakris GL.
    JAMA Cardiol; 2023 Aug 01; 8(8):732-741. PubMed ID: 37314801
    [Abstract] [Full Text] [Related]

  • 10. Effect of Dapagliflozin on Cardiovascular Outcomes According to Baseline Kidney Function and Albuminuria Status in Patients With Type 2 Diabetes: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
    Zelniker TA, Raz I, Mosenzon O, Dwyer JP, Heerspink HHJL, Cahn A, Goodrich EL, Im K, Bhatt DL, Leiter LA, McGuire DK, Wilding JPH, Gause-Nilsson I, Langkilde AM, Sabatine MS, Wiviott SD.
    JAMA Cardiol; 2021 Jul 01; 6(7):801-810. PubMed ID: 33851953
    [Abstract] [Full Text] [Related]

  • 11. Insulin resistance, diabetic kidney disease, and all-cause mortality in individuals with type 2 diabetes: a prospective cohort study.
    Penno G, Solini A, Orsi E, Bonora E, Fondelli C, Trevisan R, Vedovato M, Cavalot F, Zerbini G, Lamacchia O, Nicolucci A, Pugliese G, Renal Insufficiency And Cardiovascular Events (RIACE) Study Group.
    BMC Med; 2021 Mar 15; 19(1):66. PubMed ID: 33715620
    [Abstract] [Full Text] [Related]

  • 12. Finerenone Reduces Risk of Incident Heart Failure in Patients With Chronic Kidney Disease and Type 2 Diabetes: Analyses From the FIGARO-DKD Trial.
    Filippatos G, Anker SD, Agarwal R, Ruilope LM, Rossing P, Bakris GL, Tasto C, Joseph A, Kolkhof P, Lage A, Pitt B, FIGARO-DKD Investigators.
    Circulation; 2022 Feb 08; 145(6):437-447. PubMed ID: 34775784
    [Abstract] [Full Text] [Related]

  • 13. Clinical outcomes in patients with type 2 diabetes mellitus-related kidney disease: A Jordanian population cohort study.
    Farah R, Alhajahjeh A, Nofal A, Hyasat TB, Abu Jabeh RAH, Suboh LT, Alhawari H, Momani MS, Jaber HJ, AlAwwa I.
    J Diabetes Complications; 2023 Jun 08; 37(6):108478. PubMed ID: 37084653
    [Abstract] [Full Text] [Related]

  • 14. Kidney disease progression and all-cause mortality across estimated glomerular filtration rate and albuminuria categories among patients with vs. without type 2 diabetes.
    Nichols GA, Déruaz-Luyet A, Brodovicz KG, Kimes TM, Rosales AG, Hauske SJ.
    BMC Nephrol; 2020 May 07; 21(1):167. PubMed ID: 32380961
    [Abstract] [Full Text] [Related]

  • 15. Kidney outcomes with finerenone: an analysis from the FIGARO-DKD study.
    Ruilope LM, Pitt B, Anker SD, Rossing P, Kovesdy CP, Pecoits-Filho R, Pergola P, Joseph A, Lage A, Mentenich N, Scheerer MF, Bakris GL.
    Nephrol Dial Transplant; 2023 Feb 13; 38(2):372-383. PubMed ID: 35451488
    [Abstract] [Full Text] [Related]

  • 16. Diabetic kidney disease and risk of incident stroke among adults with type 2 diabetes.
    Kaze AD, Jaar BG, Fonarow GC, Echouffo-Tcheugui JB.
    BMC Med; 2022 Mar 29; 20(1):127. PubMed ID: 35346165
    [Abstract] [Full Text] [Related]

  • 17. Kidney function measures and cardiovascular outcomes in people with diabetes: the Hoorn Diabetes Care System cohort.
    Dal Canto E, Elders PJM, van der Heijden AA, van Ballegooijen AJ, Lissenberg-Witte BI, Rutters F, Beulens JWJ.
    Diabetologia; 2023 Mar 29; 66(3):482-494. PubMed ID: 36347992
    [Abstract] [Full Text] [Related]

  • 18. Heart failure hospitalisation relative to major atherosclerotic events in type 2 diabetes with versus without chronic kidney disease: A meta-analysis of cardiovascular outcomes trials.
    Sacre JW, Magliano DJ, Shaw JE.
    Diabetes Metab; 2021 Sep 29; 47(5):101249. PubMed ID: 33744399
    [Abstract] [Full Text] [Related]

  • 19. Cardiovascular risk and renal injury profile in subjects with type 2 diabetes and non-albuminuric diabetic kidney disease.
    Di Marco M, Scilletta S, Miano N, Marrano N, Natalicchio A, Giorgino F, Di Mauro S, Filippello A, Scamporrino A, Tribulato P, Bosco G, Di Giacomo Barbagallo F, Scicali R, Milluzzo A, Ballirò T, Frittitta L, Castellino P, Purrello F, Piro S, Di Pino A.
    Cardiovasc Diabetol; 2023 Dec 13; 22(1):344. PubMed ID: 38093293
    [Abstract] [Full Text] [Related]

  • 20. Kidney Function as Risk Factor and Predictor of Cardiovascular Outcomes and Mortality Among Older Adults.
    Kühn A, van der Giet M, Kuhlmann MK, Martus P, Mielke N, Ebert N, Schaeffner ES.
    Am J Kidney Dis; 2021 Mar 13; 77(3):386-396.e1. PubMed ID: 33197533
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 59.